| Literature DB >> 15333479 |
Patrick J Manning1, Wayne H F Sutherland, Robert J Walker, Sheila M Williams, Sylvia A De Jong, Anne R Ryalls, Elizabeth A Berry.
Abstract
OBJECTIVE: Markers of oxidative stress and plasma alanine transferase (ALT) levels are increased and circulating antioxidant concentrations are reduced in individuals with insulin resistance. Vitamin E improves glycemic control in people with diabetes. We tested the hypothesis that vitamin E would decrease markers of oxidative stress and plasma ALT levels and improve insulin sensitivity in overweight individuals. RESEARCH DESIGN AND METHODS: Eighty overweight individuals (BMI >27 kg/m(2)) were randomly allocated to receive either 800 IU vitamin E per day or a matching placebo for 3 months. The dose of vitamin E was increased to 1,200 IU per day for a further 3 months.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15333479 DOI: 10.2337/diacare.27.9.2166
Source DB: PubMed Journal: Diabetes Care ISSN: 0149-5992 Impact factor: 19.112